508 related articles for article (PubMed ID: 35036354)
21. Patient-Specific Organoid and Organ-on-a-Chip: 3D Cell-Culture Meets 3D Printing and Numerical Simulation.
Zheng F; Xiao Y; Liu H; Fan Y; Dao M
Adv Biol (Weinh); 2021 Jun; 5(6):e2000024. PubMed ID: 33856745
[TBL] [Abstract][Full Text] [Related]
22. Tumor organoids: synergistic applications, current challenges, and future prospects in cancer therapy.
Qu J; Kalyani FS; Liu L; Cheng T; Chen L
Cancer Commun (Lond); 2021 Dec; 41(12):1331-1353. PubMed ID: 34713636
[TBL] [Abstract][Full Text] [Related]
23. A synopsis of prostate organoid methodologies, applications, and limitations.
Gleave AM; Ci X; Lin D; Wang Y
Prostate; 2020 May; 80(6):518-526. PubMed ID: 32084293
[TBL] [Abstract][Full Text] [Related]
24. Application Progress of Organoids in Colorectal Cancer.
Luo L; Ma Y; Zheng Y; Su J; Huang G
Front Cell Dev Biol; 2022; 10():815067. PubMed ID: 35273961
[TBL] [Abstract][Full Text] [Related]
25. Organoid biobanks as a new tool for pre-clinical validation of candidate drug efficacy and safety.
Botti G; Di Bonito M; Cantile M
Int J Physiol Pathophysiol Pharmacol; 2021; 13(1):17-21. PubMed ID: 33815668
[TBL] [Abstract][Full Text] [Related]
26. Patient-Derived Cancer Organoids for Precision Oncology Treatment.
Pernik MN; Bird CE; Traylor JI; Shi DD; Richardson TE; McBrayer SK; Abdullah KG
J Pers Med; 2021 May; 11(5):. PubMed ID: 34067714
[TBL] [Abstract][Full Text] [Related]
27. The role of organoids in cancer research.
Fang Z; Li P; Du F; Shang L; Li L
Exp Hematol Oncol; 2023 Aug; 12(1):69. PubMed ID: 37537666
[TBL] [Abstract][Full Text] [Related]
28. Organoids: An intermediate modeling platform in precision oncology.
Jin MZ; Han RR; Qiu GZ; Ju XC; Lou G; Jin WL
Cancer Lett; 2018 Feb; 414():174-180. PubMed ID: 29174804
[TBL] [Abstract][Full Text] [Related]
29. Application of Ovarian Cancer Organoids in Precision Medicine: Key Challenges and Current Opportunities.
Yang J; Huang S; Cheng S; Jin Y; Zhang N; Wang Y
Front Cell Dev Biol; 2021; 9():701429. PubMed ID: 34409036
[TBL] [Abstract][Full Text] [Related]
30. Organoid engineering with microfluidics and biomaterials for liver, lung disease, and cancer modeling.
Kim SK; Kim YH; Park S; Cho SW
Acta Biomater; 2021 Sep; 132():37-51. PubMed ID: 33711526
[TBL] [Abstract][Full Text] [Related]
31. Organoid Cultures Derived From Patients With Papillary Thyroid Cancer.
Chen D; Tan Y; Li Z; Li W; Yu L; Chen W; Liu Y; Liu L; Guo L; Huang W; Zhao Y
J Clin Endocrinol Metab; 2021 Apr; 106(5):1410-1426. PubMed ID: 33524147
[TBL] [Abstract][Full Text] [Related]
32. Advancement of Organoid Technology in Regenerative Medicine.
Arjmand B; Rabbani Z; Soveyzi F; Tayanloo-Beik A; Rezaei-Tavirani M; Biglar M; Adibi H; Larijani B
Regen Eng Transl Med; 2023; 9(1):83-96. PubMed ID: 35968268
[TBL] [Abstract][Full Text] [Related]
33. Organoids: The current status and biomedical applications.
Yang S; Hu H; Kung H; Zou R; Dai Y; Hu Y; Wang T; Lv T; Yu J; Li F
MedComm (2020); 2023 Jun; 4(3):e274. PubMed ID: 37215622
[TBL] [Abstract][Full Text] [Related]
34. Prospective derivation of a living organoid biobank of colorectal cancer patients.
van de Wetering M; Francies HE; Francis JM; Bounova G; Iorio F; Pronk A; van Houdt W; van Gorp J; Taylor-Weiner A; Kester L; McLaren-Douglas A; Blokker J; Jaksani S; Bartfeld S; Volckman R; van Sluis P; Li VS; Seepo S; Sekhar Pedamallu C; Cibulskis K; Carter SL; McKenna A; Lawrence MS; Lichtenstein L; Stewart C; Koster J; Versteeg R; van Oudenaarden A; Saez-Rodriguez J; Vries RG; Getz G; Wessels L; Stratton MR; McDermott U; Meyerson M; Garnett MJ; Clevers H
Cell; 2015 May; 161(4):933-45. PubMed ID: 25957691
[TBL] [Abstract][Full Text] [Related]
35. Patient-derived organoids as a preclinical platform for precision medicine in colorectal cancer.
Cho YW; Min DW; Kim HP; An Y; Kim S; Youk J; Chun J; Im JP; Song SH; Ju YS; Han SW; Park KJ; Kim TY
Mol Oncol; 2022 Jun; 16(12):2396-2412. PubMed ID: 34850547
[TBL] [Abstract][Full Text] [Related]
36. Organoid technology in cancer precision medicine.
Xia X; Li F; He J; Aji R; Gao D
Cancer Lett; 2019 Aug; 457():20-27. PubMed ID: 31078736
[TBL] [Abstract][Full Text] [Related]
37. Human Brain Organoid: A Versatile Tool for Modeling Neurodegeneration Diseases and for Drug Screening.
Ma C; Seong H; Li X; Yu X; Xu S; Li Y
Stem Cells Int; 2022; 2022():2150680. PubMed ID: 36061149
[TBL] [Abstract][Full Text] [Related]
38. The pivotal application of patient-derived organoid biobanks for personalized treatment of gastrointestinal cancers.
Yu YY; Zhu YJ; Xiao ZZ; Chen YD; Chang XS; Liu YH; Tang Q; Zhang HB
Biomark Res; 2022 Oct; 10(1):73. PubMed ID: 36207749
[TBL] [Abstract][Full Text] [Related]
39. Deciphering the Tumor Microenvironment of Colorectal Cancer and Guiding Clinical Treatment With Patient-Derived Organoid Technology: Progress and Challenges.
Li J; Liu J; Xia W; Yang H; Sha W; Chen H
Technol Cancer Res Treat; 2024; 23():15330338231221856. PubMed ID: 38225190
[TBL] [Abstract][Full Text] [Related]
40. Probing prodrug metabolism and reciprocal toxicity with an integrated and humanized multi-tissue organ-on-a-chip platform.
Rajan SAP; Aleman J; Wan M; Pourhabibi Zarandi N; Nzou G; Murphy S; Bishop CE; Sadri-Ardekani H; Shupe T; Atala A; Hall AR; Skardal A
Acta Biomater; 2020 Apr; 106():124-135. PubMed ID: 32068138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
